Concepedia
Statistics
Publications
12
Citations
503
H-Index
Active since
1970
Affiliations
Abbott (United Kingdom)(Current)
Abbott (United States)
Abbott Fund
Discovery Laboratories (United States)
Thomas Herrin is an author at Abbott (United Kingdom) specializing in medicinal chemistry, pharmacology, and pharmacy.
Publications per year
1970–2004
Cyclobut-A and cyclobut-G: broad-spectrum antiviral agents with potential utility for the therapy of AIDS
Daniel W. Norbeck, Earl R. Kern, Seiji Hayashi et al. · Journal of Medicinal Chemistry · 1990 · 121 citations
Pharmacy, Medicinal Chemistry, Pharmacology +17
A Novel, Picomolar Inhibitor of Human Immunodeficiency Virus Type 1 Protease
Hing L. Sham, Chen Zhao, Kent D. Stewart et al. · Journal of Medicinal Chemistry · 1996 · 62 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +15
Design of orally bioavailable, symmetry-based inhibitors of HIV protease
Dale J. Kempf, Kennan C. Marsh, Lynnmarie Codacovi Fino et al. · Bioorganic & Medicinal Chemistry · 1994 · 56 citations
Pharmacy, Medicinal Chemistry, Pharmacology +14
Acyl tetramic acids. 6. Synthesis of 3-dienoyl tetramic acids related to streptolydigin and tirandamycin
Ving J. Lee, Alan R. Branfman, Thomas Herrin et al. · Journal of the American Chemical Society · 1978 · 54 citations
Natural Sciences, Biochemistry, Chemistry +6
Developments in the nonenzymic biogenetic-like steroid synthesis
William S. Johnson, Tsung-Tee Li, Charles A. Harbert et al. · Journal of the American Chemical Society · 1970 · 44 citations
Life Sciences, Biochemistry, Bioisosterism +5
1–5 of 12